scholarly journals The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma

2012 ◽  
Vol 25 (8) ◽  
pp. 1098-1105 ◽  
Author(s):  
Isil Z Yildiz-Aktas ◽  
David J Dabbs ◽  
Rohit Bhargava
Keyword(s):  
Estrogen Receptor ◽  
Breast Carcinoma ◽  
Progesterone Receptor ◽  
Invasive Breast Carcinoma ◽  
Her2 Expression ◽  
Ischemic Time ◽  
Cold Ischemic Time

Effect of prolonged cold ischemic time on immunohistochemical testing of estrogen receptor, progesterone receptor, and HER2 expression in breast cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e11505-e11505
Author(s):  
Tae-Kyung Yoo ◽  
Hyeong-Gon Moon ◽  
Jisun Kim ◽  
Jun Woo Lee ◽  
Min Kyoon Kim ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Progesterone Receptor ◽  
Her2 Expression ◽  
Ischemic Time ◽  
Cold Ischemic Time ◽  
Immunohistochemical Testing

scholarly journals The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma

2012 ◽  
Vol 137 (5) ◽  
pp. 691-698 ◽  
Author(s):  
Isil Z. Yildiz-Aktas ◽  
David J. Dabbs ◽  
Kristine L. Cooper ◽  
Mamatha Chivukula ◽  
Kim McManus ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Breast Carcinoma ◽  
Progesterone Receptor ◽  
Invasive Breast Carcinoma ◽  
Formalin Fixation ◽  
Her2 Expression

Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients

2017 ◽  
Vol 65 ◽  
pp. 123-132 ◽  
Author(s):  
Kamaljeet Singh ◽  
Yihong Wang ◽  
Shivali Marketkar ◽  
Elizabeth T. Kalife ◽  
Margaret M. Steinhoff
Keyword(s):  
Estrogen Receptor ◽  
Retrospective Study ◽  
Breast Carcinoma ◽  
Progesterone Receptor ◽  
Invasive Breast Carcinoma

scholarly journals Utility of Estrogen Receptor, Progesterone Receptor, and HER-2/neuAnalysis of Multiple Foci in Multifocal Ipsilateral Invasive Breast Carcinoma

2015 ◽  
Vol 144 (6) ◽  
pp. 952-959 ◽  
Author(s):  
Ellen G. East ◽  
Judy C. Pang ◽  
Kelley M. Kidwell ◽  
Julie M. Jorns
Keyword(s):  
Estrogen Receptor ◽  
Breast Carcinoma ◽  
Progesterone Receptor ◽  
Invasive Breast Carcinoma ◽  
Her 2

scholarly journals Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma

Cancer ◽  
2004 ◽  
Vol 103 (1) ◽  
pp. 164-173 ◽  
Author(s):  
Edwin R. Fisher ◽  
Stewart Anderson ◽  
Scott Dean ◽  
David Dabbs ◽  
Bernard Fisher ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Breast Carcinoma ◽  
Progesterone Receptor ◽  
Invasive Breast Carcinoma

Immunohistochemical and Clinicopathologic Characteristics of Invasive Ductal Carcinoma of Breast With Micropapillary Carcinoma Component

2005 ◽  
Vol 129 (10) ◽  
pp. 1277-1282 ◽  
Author(s):  
Mi-Jung Kim ◽  
Gyungyub Gong ◽  
Hee Jae Joo ◽  
Se-Hyun Ahn ◽  
Jae Y. Ro
Keyword(s):  
Estrogen Receptor ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Breast Carcinoma ◽  
Epidermal Growth Factor ◽  
Growth Factor Receptor ◽  
Invasive Breast Carcinoma ◽  
Nodal Metastases ◽  
Micropapillary Carcinoma ◽  
Epidermal Growth

Abstract Context.—A micropapillary carcinoma (MC) component is generally considered to behave aggressively. Although several reports have described the prognostic significance of MC in breast carcinomas, immunohistochemical findings of MC, especially as compared to non-MC, are rarely described. Objective.—We compared clinicopathologic and immunohistochemical findings between 38 cases of invasive breast carcinoma with an MC component (IMC) and 217 cases of invasive breast carcinoma without an MC component (NIMC). Design.—We constructed a tissue microarray from 38 cases of IMC and performed immunohistochemical stainings for cytokeratin (CK) 7, CK20, estrogen receptor, progesterone receptor, p53, c-Erb-B2, CD34, CK5, epidermal growth factor receptor, and c-Kit in both MC and non-MC components. Results.—Cases with IMC were associated with greater tumor size, more frequent lymphovascular invasion, nodal metastases, greater mean numbers of positive lymph nodes, and higher stage than those with NIMC, but were not associated with poorer survival rates. On immunohistochemistry, only p53 reactivity was statistically different between MC and non-MC components in IMC cases. Estrogen receptor positivity tended to be lower in MC than non-MC, but the difference was not significant. Most of the MCs and non-MCs in IMC cases were positive for CK7, but none of them were positive for CK20, CK5, epidermal growth factor receptor, or c-Kit. Conclusions.—Based on the frequent nodal metastases and association with higher stage found in IMC as compared with NIMC cases, as well as higher p53 positivity and lower frequency of estrogen receptor expression, MC could be considered an aggressive histologic type of breast carcinoma. In both MC and non-MC components in IMC cases, no basallike immunostaining pattern was detected.

Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma

2018 ◽  
Vol 172 (3) ◽  
pp. 671-677 ◽  
Author(s):  
Jing Li Huang ◽  
Scott Kizy ◽  
Schelomo Marmor ◽  
Ariella Altman ◽  
Anne Blaes ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Progesterone Receptor ◽  
Early Stage ◽  
Recurrence Score ◽  
Tumor Grade ◽  
Invasive Breast Carcinoma ◽  
Progesterone Receptor Status ◽  
Receptor Status
Sign in / Sign up

Export Citation Format

Share Document